Management of Multiple Uterine Fibroids

Initial Treatment Approach

Medical management should be trialed first before pursuing invasive therapies for patients with multiple uterine fibroids, regardless of fertility desires, as recommended by the American College of Radiology 1, 2, 3
The treatment algorithm depends critically on three factors: symptom type, fertility desires, and fibroid characteristics, according to the American College of Radiology 1, 3

For heavy menstrual bleeding, start with NSAIDs, tranexamic acid, combined hormonal contraceptives, or levonorgestrel-releasing IUD as first-line options for bleeding control, as recommended by the American College of Obstetricians and Gynecologists 2, 3
Tranexamic acid provides an excellent nonhormonal alternative for patients who cannot or prefer not to use hormonal options, with significant reduction in menstrual blood loss, as reported by the American College of Obstetricians and Gynecologists 2, 3
For bulk symptoms, oral GnRH antagonists with hormone add-back therapy are the most effective medical option, reducing fibroid volume by 18-30%, as recommended by the American College of Obstetricians and Gynecologists 2, 3

For patients desiring future pregnancy, laparoscopic or open myomectomy is the primary surgical option for symptomatic multiple fibroids, as recommended by the American College of Radiology 1, 3
For patients not desiring future fertility, hysterectomy provides definitive resolution with patient satisfaction rates up to 90% and should be offered as the most effective treatment, as recommended by the American College of Obstetricians and Gynecologists 3
Uterine artery embolization is an effective minimally invasive alternative, improving symptoms and quality of life for up to 7 years, with a 7% reintervention rate for persistent symptoms, as reported by the American College of Radiology 3

For multiple fibroids with concurrent adenomyosis, medical management or uterine artery embolization are the preferred initial approaches, as recommended by the American College of Radiology 1, 3
For postmenopausal patients, hysterectomy is the appropriate next step for symptomatic patients after negative endometrial evaluation, as recommended by the American College of Radiology 1, 3

Correct anemia before elective surgery using GnRH agonists/antagonists or selective progesterone receptor modulators, which effectively reduce bleeding and improve hemoglobin, as recommended by the American College of Obstetricians and Gynecologists 2
Provide concurrent iron supplementation during preoperative medical therapy, as recommended by the American College of Obstetricians and Gynecologists 2

Most medical treatments provide only temporary symptom relief, with symptoms typically recurring rapidly after discontinuation, as reported by the American College of Obstetricians and Gynecologists 2
Fertility is suppressed during GnRH agonist/antagonist treatment, requiring discontinuation before attempting conception, as reported by the American College of Obstetricians and Gynecologists 2
MRgFUS has a higher reintervention rate compared to uterine artery embolization, making it less durable for multiple fibroids, as reported by the American College of Radiology 4